Comparison of Survival Outcomes Between Patients With Malignant Mixed Mullerian Tumors and High-Grade Endometrioid, Clear Cell, and Papillary Serous Endometrial Cancers-Reference-Cited by-同舟云学术

Comparison of Survival Outcomes Between Patients With Malignant Mixed Mullerian Tumors and High-Grade Endometrioid, Clear Cell, and Papillary Serous Endometrial Cancers

Published:2011-07 Issue:5 Volume:21 Page:877-884
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Felix Ashley Sinclair,Stone Roslyn A.,Bowser Robert,Chivukula Mamatha,Edwards Robert P.,Weissfeld Joel L.,Linkov Faina

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference24 articles.

1. Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome

2. Prognostic Factors for Malignant Mixed Mullerian Tumors of the Uterus

3. Patterns of recurrence in malignant mixed müllerian tumor of the uterus

4. Management of malignant, mixed mesodermal tumors of the uterus

5. Clinicopathologic analysis of uterine malignant mixed müllerian tumors

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI Radiomics Data Analysis for Differentiation between Malignant Mixed Müllerian Tumors and Endometrial Carcinoma;Cancers;2024-07-25

2. Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes;Cancers;2024-01-17

3. The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center;Journal of Clinical Medicine;2023-04-26

4. Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival;Strahlentherapie und Onkologie;2023-03-17

5. Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma;International Journal of Gynecologic Cancer;2022-09-02